| Arg1 | Arginase-1 |
| BMDMs | Bone marrow-derived macrophages |
| BSYS | Bu Shen Yi Sui capsule |
| CCL2 | C-C motif chemokine ligand 2 |
| CCL3 | C-C motif chemokine ligand 3 |
| CD74 | Major histocompatibility complex, class II invariant chain |
| C/EBP-α | CCAAT/enhancer-binding protein-α |
| CNS | Central nervous system |
| DR | Diabetic retinopathy |
| EAE | Experimental autoimmune encephalomyelitis |
| ERG | Electroretinography GCL ganglion cell layer |
| Flot1 | Flottilin-1 |
| Gapdh | Glyceraldehyde 3-phosphate dehydrogenase |
| GS | Glutamine synthetase |
| IFN-γ | Interferon gamma |
| IL-1β | Interleukin-1β |
| IL-10 | Interleukin-10 |
| ILM | Inner limiting membrane |
| INL | Inner nuclear layer |
| IPL | Inner plexiform layer |
| MHC-II | Major histocompatibility complex class II molecule |
| miR-124 | MicroRNA-124 |
| miR-inh | MicroRNA-124 inhibitor |
| NVU | Neurovascular unit |
| OLM | Outer limiting membrane |
| ONL | Outer nuclear layer |
| OPL | Outer plexiform layer |
| PD | Photo-oxidative damage |
| PKD | Polycystic kidney disease |
| PU.1 | Protein binding U box |
| SCI | Spinal cord injury |
| SD | Sprague Dawley |
| Spi1 | Salmonella Pathogenicity Island 1 (gene name of PU.1) |
| TNF-α | Tumor necrosis factor-α |
| TNFR | TNF receptor |